SHRESTHA DUTTA, AMITY UNIVERSITY KOLKATA
Daikenchuto (DKT) is a conventional herbal (Kampo) medication in Japan that involves three therapeutic herbs: ginseng (Panax ginseng), Japanese pepper (Zanthoxylum piperitum) or Chinese pepper (Zanthoxylum bungeanum), and prepared ginger (Zingiber officinale). DKT is made by blending the herbs, then by extraction utilizing boiling water lastly by converting this extract into a powder or delicate structure.
Treatment with DKT relieves gastrointestinal dysmotility by raising defecation frequency and diminishing bowel gas in patients after a complete gastrectomy. The constituents of DKT are assimilated as well as metabolized at various rates. The principal active constituent of Japanese pepper, hydroxysanshool, is quickly ingested before arriving at the colon. The fundamental active mixtures of handled ginger, 6-school, and gingerol (6G), are utilized in the upper small digestive system and liver.
The gastrointestinal tract microbiota, a multispecies microbial local area, has been appeared to interact with the host commonly and fundamental for keeping up host health. The microbial cell thickness increments consistently along the gastrointestinal tract, with the levels being low in the stomach and extremely high in the colon.
An in vitro microbiota model was set up utilizing fecal inocula gathered from nine healthy volunteers, and each model was found to hold operational taxonomic units like the ones in the first human fecal samples. DKT was added to the in vitro microbiota model culture at a concentration of 0.5% by weight. Next-generation sequencing of bacterial 16S rRNA gene uncovered an important increase in the overall abundance of bacterial microbes identified with the Bifidobacterium genus in the model after brooding with DKT.
In pure cultures, Daikenchuto fundamentally advanced the development of Bifidobacterium adolescentis, yet not that of Fusobacterium nucleatum or Escherichia coli. Moreover, in pure cultures, B. adolescentis changed ginsenoside Rc to Rd, which was then presumably used for its development. Our investigation uncovers the in vitro bifidogenic impact of DKT that probably adds to its beneficial consequences for the human colon.
Also read:New species of bacterial strains discovered at the International Space Station!
Reference : Sasaki, K., Sasaki, D., Sasaki, K. et al. Growth stimulation of Bifidobacterium from human colon using daikenchuto in an in vitro model of human intestinal microbiota. Sci Rep 11, 4580 (2021). https://doi.org/10.1038/s41598-021-84167-z
One thought on “DAIKENCHUTO: A JAPANESE HERBAL MEDICATION METHOD”